Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 2 |
2018 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.
J Clin Invest. 2017 Jun 1;127(6):2081-2090. doi: 10.1172/JCI89548. Epub 2017 May 15.
J Clin Invest. 2017.
PMID: 28504649
Free PMC article.
RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.
Wang Y, Deng O, Feng Z, Du Z, Xiong X, Lai J, Yang X, Xu M, Wang H, Taylor D, Yan C, Chen C, Difeo A, Ma Z, Zhang J.
Wang Y, et al.
Oncogene. 2016 Mar 17;35(11):1363-72. doi: 10.1038/onc.2015.198. Epub 2015 Aug 3.
Oncogene. 2016.
PMID: 26234677
Free PMC article.
Item in Clipboard
Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
Nagaraj AB, Wang QQ, Joseph P, Zheng C, Chen Y, Kovalenko O, Singh S, Armstrong A, Resnick K, Zanotti K, Waggoner S, Xu R, DiFeo A.
Nagaraj AB, et al.
Oncogene. 2018 Jan 18;37(3):403-414. doi: 10.1038/onc.2017.328. Epub 2017 Oct 2.
Oncogene. 2018.
PMID: 28967908
Free PMC article.
Item in Clipboard
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL.
Kremer-Tal S, et al.
J Hepatol. 2007 Apr;46(4):645-54. doi: 10.1016/j.jhep.2006.10.012. Epub 2006 Nov 27.
J Hepatol. 2007.
PMID: 17196295
Free PMC article.
Item in Clipboard
Drug Intervention Response Predictions with PARADIGM (DIRPP) identifies drug resistant cancer cell lines and pathway mechanisms of resistance.
Brubaker D, Difeo A, Chen Y, Pearl T, Zhai K, Bebek G, Chance M, Barnholtz-Sloan J.
Brubaker D, et al.
Pac Symp Biocomput. 2014:125-35.
Pac Symp Biocomput. 2014.
PMID: 24297540
Free PMC article.
Item in Clipboard
Cite
Cite